- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06770335
The FLaME Cognitive Rehabilitation Study for Childhood Brain Tumour (FLaME)
Strategy-based Cognitive Rehabilitation with Integrated Fatigue Management for Patients with Paediatric Brain Tumour (PBT): an Acceptability and Feasibility Study of the Fatigue, Learning and Memory Enrichment (FLaME) Intervention
Study Overview
Status
Conditions
Detailed Description
Treatment advances for childhood brain tumour in recent decades have substantially improved mortality rates but come at significant cost to the child's cognitive abilities, alongside the effects of the tumour itself. Up to 100% of children treated for a brain tumour experience some degree of cognitive difficulty despite most having achieved typical cognitive development prior to diagnosis. In most cases the child will experience multiple cognitive difficulties (e.g., with memory, attention, and speed of processing) that severely impact quality of life, mental health, access to education, academic and vocational attainment, and progress towards becoming an independent adult. These cognitive difficulties often emerge and become more severe over time (called 'late effects'). These difficulties have been frequently found in research studies and have informed a strong emphasis on the need for neurorehabilitation in national guidance for childhood brain tumour (e.g. NICE, 2005). Interventions aimed to address cognitive difficulties and support children to resume their developmental trajectory as closely as possible are clearly paramount. However, recent evidence finds that the recommendation for neurorehabilitation is rarely implemented, with cognitive rehabilitation almost entirely unavailable. Poor adherence to national guidance is compounded by the very limited research into cognitive rehabilitation interventions for children treated for brain tumour. The few interventions tried have also had poor feasibility of implementation (e.g., low completion rates) and low acceptability for patients and families.
Cognitive rehabilitation interventions typically involve either 1) 'massed drill-based' practice (sometimes called 'brain training') on cognitive training tasks where the individual repeats a cognitive training exercises over many sessions such as remembering an array of dots; 2) strategy-based approaches which teach strategies to optimise cognition (e.g., memory techniques such as mnemonics), and/or 3) external compensatory aids (e.g., visual reminders). There are few studies of cognitive rehabilitation for children with brain tumour, particularly good quality trials. A small number of studies have focused on drill-based rehabilitation, however, the feasibility and acceptability for this approach for children with brain tumour is low and has well documented problems in poor generalisation to skills beyond the repetitively trained task and poor maintenance of improvements. Rehabilitation in childhood brain injury has greatest potential when it includes cognitive strategy-use, is adapted for developmental level, involves systemic support, and empowers children to develop their own strategies. There is currently one good quality trial of a cognitive rehabilitation intervention that incorporates strategy-use for children with brain tumour. The intervention resulted in improvements in academic attainments and parental report of child attention skills, but with small effect sizes. The program also included a demanding drill-based practice component (requiring 50 hours in total), with only 60% of participants completing the intervention. A subsequent study omitted the drill-based practice and extended the strategy-use component, combining it with parent and teacher strategy support in a smaller pilot study. The power and generalisability of the findings are limited by a small sample size, however some improvements for cognition were found. Parents and children also rated high levels of satisfaction, particularly because the intervention improved their understanding of their cognitive strengths and weakness. Despite some promising findings for strategy-based cognitive rehabilitation, poor feasibility continues to be reflected in low completion rates. No cognitive rehabilitation intervention has addressed the high prevalence of cognitive fatigue (extreme mental tiredness) for children with brain tumours that could predictably limit engagement and completion of interventions. Despite strong recommendations a targeted intervention has yet to be developed for cognitive fatigue for children with brain tumours.
The research was designed to answer two key questions where there is a substantial evidence gap: 1) is a novel strategy-based cognitive rehabilitation intervention acceptable and feasible to children treated for brain tumour and their families, and 2) does adding fatigue management to the intervention improve feasibility and acceptability. The intervention is called The Fatigue, Learning and Memory Enrichment [FLaME] programme. The findings will tell us about the feasibility, acceptability, and preliminary outcomes of the FLaME programme. That is, it will tell us if there are any barriers to putting this intervention in place for young people with brain tumours, how acceptable they find it, and what the level of demand and satisfaction there is with the intervention. We will also seek preliminary information about intervention effectiveness to inform the optimum outcome measurement. This information will inform progress to a larger scale randomised controlled trial (RCT) to meet a substantial evidence gap in an under-researched group. There has been no cognitive rehabilitation trial for childhood brain tumour in the UK before, including within the National Health Service.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Charlotte P Malcolm, DClinPsy
- Phone Number: 0146 +442074059200
- Email: charlotte.malcolm@gosh.nhs.uk
Study Contact Backup
- Name: Tara Murphy, DClinPsy
- Phone Number: 0146 +442074059200
- Email: tara.murphy@gosh.nhs.uk
Study Locations
-
-
-
London, United Kingdom, WC1N 3JH
- Great Ormond Street Hospital for Children
-
Contact:
- Tara Murphy, DClinPsy
- Phone Number: 0146 +442074059200
- Email: tara.murphy@gosh.nhs.uk
-
Contact:
- Charlotte P Malcolm, DClinPsy
- Phone Number: 0146 +4402074059200
- Email: charlotte.malcolm@gosh.nhs.uk
-
Contact:
- Charlotte P Malcolm, DClinPsy
-
Contact:
- Faraneh Vargha-Khadem, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age range: 7 years to 17 years, 11 months.
- Received diagnosis and/or treatment/surveillance at GOSH for a childhood tumour that involved the CNS (brain) and/or oncology treatment to brain.
- Received or receiving a neuropsychological assessment/consultation at GOSH over the course of the study period or in the 48 months prior to the study period, or under active surveillance with the neuro-oncology multidisciplinary team during the study period.
- At least 6 months post-diagnosis/acute treatment (surgery and/or radiotherapy), and 3 months post-return to school, with stable disease.
- One or more scores outside of normal limits (i.e. 1 SD above or below the mean in the direction indicating difficulty) in at least one neuropsychological domain (on performance-based tests or questionnaire-based rating scales).
- Report impairment (z-score > -0.67) in fatigue on one or more subscales of the PedsQL Multidimensional Fatigue Scale.
- Capacity/competence of patient or parent/carer to provide informed
Exclusion Criteria:
- Completed or having another targeted formal psychological intervention for cognitive rehabilitation or fatigue in the past 6 months.
- Sensorimotor (e.g., visual-motor) impairment only on neuropsychological assessment without additional cognitive difficulty.
- Current substance misuse from self-report.
- Currently receiving formal psychiatric care for a diagnosed mental health disorder (including active suicidal ideation), excluding ADHD treatment (if a child has a diagnosis of ADHD they should be treated).
- Intellectual Disability based on a standard score of more than 2 standard deviations below the mean on a general adaptive behaviour composite and, where available, the General Ability Index of intellect.
- Patient and parent/carer is unable to communicate verbally and in written form in English.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Cognitive rehabilitation with fatigue management
A 12-week block of intervention (strategy-based cognitive rehabilitation with fatigue management)
|
A novel strategy-based cognitive rehabilitation intervention that can be delivered with or without cognitive fatigue management.
Skills are targeted sequentially based on a developmental hierarchical model where cognitive fatigue can be addressed first, followed by adult-supported compensatory strategies, with independent use of strategies for specific impairments delivered only once these earlier levels have been addressed.
The 'FLaME' program incorporates strategies that have been trialled and found successful in fatigue (e.g., pacing and activity scheduling) and cognitive rehabilitation (e.g., chunking, elaborative encoding techniques) interventions for children.
The intervention address two key issues: 1) to deliver strategy-based cognitive rehabilitation as an alternative to prevailing drill-based approaches, and 2) to integrate fatigue management to improve feasibility and acceptability of cognitive rehabilitation.
This arm include the full intervention.
|
|
Experimental: Cognitive rehabilitation only
A 6-week block of intervention (strategy-based cognitive rehabilitation alone)
|
A novel strategy-based cognitive rehabilitation intervention that can be delivered with or without cognitive fatigue management.
Skills are targeted sequentially based on a developmental hierarchical model where cognitive fatigue can be addressed first, followed by adult-supported compensatory strategies, with independent use of strategies for specific impairments delivered only once these earlier levels have been addressed.
The 'FLaME' program incorporates strategies that have been trialled and found successful in fatigue (e.g., pacing and activity scheduling) and cognitive rehabilitation (e.g., chunking, elaborative encoding techniques) interventions for children.
The intervention address two key issues: 1) to deliver strategy-based cognitive rehabilitation as an alternative to prevailing drill-based approaches, and 2) to integrate fatigue management to improve feasibility and acceptability of cognitive rehabilitation.
This arm includes the cognitive rehabilitation only.
|
|
No Intervention: Standard care
Standard care only
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Goal Based Outcome for management of fatigue
Time Frame: From enrolment to week 14
|
The GBO tool is a way of evaluating progress towards goals in clinical work with children, young people, and their families and carers.
The GBO compares how far a child or young person feels they have moved towards reaching a goal that they have set for themselves at the beginning of an intervention, on a scale between 0 and 10. 1-3 therapeutic goals are developed collaboratively with a psychologist
|
From enrolment to week 14
|
|
Goal Based Outcome for management of cognitive difficulty
Time Frame: From enrolment to week 14
|
The GBO tool is a way of evaluating progress towards goals in clinical work with children, young people, and their families and carers.
The GBO compares how far a child or young person feels they have moved towards reaching a goal that they have set for themselves at the beginning of an intervention, on a scale between 0 and 10. 1-3 therapeutic goals are developed collaboratively with a psychologist
|
From enrolment to week 14
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Multidimensional Fatigue Scale
Time Frame: From enrolment to week 14
|
A self-report symptom-specific instrument to measure fatigue in patients with acute and chronic health conditions.
Multiple dimensions of fatigue are measured including general fatigue, sleep/rest fatigue, and cognitive fatigue.
|
From enrolment to week 14
|
|
Individual daily fatigue analogue scale
Time Frame: From enrolment to week 14
|
Rating of subjective fatigue from 0-10 (0 = no fatigue, 10 = severe fatigue) for the morning and afternoon
|
From enrolment to week 14
|
|
% School attendance
Time Frame: From enrolment to week 14
|
UK Govt.
method: each day = 2 sessions and averaged per term and conventional threshold of >=10% of sessions missed as persistent absence)
|
From enrolment to week 14
|
|
Behaviour Rating Inventory of Executive Function, Second Edition (BRIEF2)
Time Frame: From enrolment to week 14
|
The BRIEF2 screens for executive function skills/difficulties in children and adolescents ages 5 to 18 years.
Three domains evaluate cognitive, behavioural, and emotional regulation, and a Global Executive Composite score provides and overall evaluation of executive functioning
|
From enrolment to week 14
|
|
Paediatric Quality of Life Inventory (PedsQL) Core + Brain Tumour Module Cognitive Problems scale
Time Frame: From enrolment to week 14
|
The core PedsQL is a brief measure of health-related quality of life in children and young people and includes scales on physical functioning, emotional functioning, social functioning, and school functioning.
Additional modules can be added for common quality of life difficulties in specific health populations.
The Brain Tumour module includes a cognitive problems scale of seven items on the specific cognitive difficulties young people with brain tumours frequently report.
|
From enrolment to week 14
|
|
The Brief Illness Perceptions Questionnaire (BIPQ)
Time Frame: From enrolment to week 14
|
A brief measure of how an individual cognitively and emotionally represents their illness and its impact.
|
From enrolment to week 14
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Charlotte P Malcolm, DClinPsy, Great Ormond Street Hospital for Children NHS Foundation Trust
- Principal Investigator: Faraneh Vargha-Khadem, PhD, Great Ormond Street Hospital for Children NHS Foundation Trust
Publications and helpful links
General Publications
- Simons DJ, Boot WR, Charness N, Gathercole SE, Chabris CF, Hambrick DZ, Stine-Morrow EA. Do "Brain-Training" Programs Work? Psychol Sci Public Interest. 2016 Oct;17(3):103-186. doi: 10.1177/1529100616661983.
- Irestorm E, Ora I, Linge H, Tonning Olsson I. Cognitive Fatigue and Processing Speed in Children Treated for Brain Tumours. J Int Neuropsychol Soc. 2021 Oct;27(9):865-874. doi: 10.1017/S1355617720001332. Epub 2021 Jan 14.
- Patel SK, Katz ER, Richardson R, Rimmer M, Kilian S. Cognitive and problem solving training in children with cancer: a pilot project. J Pediatr Hematol Oncol. 2009 Sep;31(9):670-7. doi: 10.1097/MPH.0b013e3181b25a1d.
- Butler RW, Copeland DR, Fairclough DL, Mulhern RK, Katz ER, Kazak AE, Noll RB, Patel SK, Sahler OJ. A multicenter, randomized clinical trial of a cognitive remediation program for childhood survivors of a pediatric malignancy. J Consult Clin Psychol. 2008 Jun;76(3):367-78. doi: 10.1037/0022-006X.76.3.367.
- Hocking MC, Paltin I, Quast LF, Barakat LP. Acceptability and Feasibility in a Pilot Randomized Clinical Trial of Computerized Working Memory Training and Parental Problem-Solving Training With Pediatric Brain Tumor Survivors. J Pediatr Psychol. 2019 Jul 1;44(6):669-678. doi: 10.1093/jpepsy/jsz015.
- Treadgold B, Kennedy C, Spoudeas H, Sugden E, Walker D, Bull K. Paediatric neuro-oncology rehabilitation in the UK: carer and provider perspectives. BMJ Paediatr Open. 2019 Dec 15;3(1):e000567. doi: 10.1136/bmjpo-2019-000567. eCollection 2019.
- Lassaletta A, Bouffet E, Mabbott D, Kulkarni AV. Functional and neuropsychological late outcomes in posterior fossa tumors in children. Childs Nerv Syst. 2015 Oct;31(10):1877-90. doi: 10.1007/s00381-015-2829-9. Epub 2015 Sep 9.
Helpful Links
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 22BO24
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pediatric Brain Tumor
-
Children's Hospital Medical Center, CincinnatiNationwide Children's HospitalRecruiting
-
TC Erciyes UniversityCompletedPediatric Cancer | Pediatric Brain Tumor | Pediatric Solid TumorTurkey
-
University of Wisconsin, MadisonRecruitingPediatric Brain Tumor | Pediatric Spine TumorUnited States
-
Washington University School of MedicineChildren's Discovery InstituteRecruitingPediatric Brain Tumor | Pediatric Solid TumorUnited States
-
Sabine Mueller, MD, PhDWashington University School of Medicine; Nationwide Children's Hospital; Cur... and other collaboratorsSuspendedPediatric Brain Tumor | Pediatric Neoplasm | Recurrent Pediatric Brain TumorUnited States
-
Memorial Sloan Kettering Cancer CenterColumbia University; University of Washington; University of Texas; Rutgers UniversityActive, not recruitingBrain Tumor | Pediatric Cancer | Pediatric Brain TumorUnited States
-
University of Alabama at BirminghamTerminated
-
University of California, San FranciscoCompletedPediatric Brain TumorsUnited States
-
Washington University School of MedicineThe Andrew McDonough B+ Foundation; Children's Discovery Institute; Neurosurgery...Recruiting
-
Aga Khan UniversityJinnah Postgraduate Medical CentreRecruitingNeurocognitive and Psychosocial Outcomes Among Pediatric Brain Tumor and Blood Cancer Patients (PBT)Blood Cancer | Brain Tumor, PediatricPakistan
Clinical Trials on THE FATIGUE, LEARNING, AND MEMORY ENRICHMENT (FLaME) INTERVENTION - Full intervention
-
University of CalgaryAlberta Children's Hospital Research Institute; Solutions for Kids in PainTerminated
-
University Hospital, GenevaUniversity of Geneva, SwitzerlandRecruiting
-
Fred Hutchinson Cancer CenterAndy Hill CARE FundRecruitingPsychiatric Disorder | Ovarian CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterBrigham and Women's Hospital; Weill Medical College of Cornell University; The... and other collaboratorsCompletedBreast Cancer | Cognitive Side Effects of Cancer Treatments | Stage I, II and III A Breast CancerUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedAcute Lymphoblastic LeukemiaUnited States, Puerto Rico
-
St. Jude Children's Research HospitalNational Cancer Institute (NCI); Genentech, Inc.Active, not recruitingMedulloblastomaUnited States, Canada, Australia, New Zealand